Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers
During the early phase of the COVID-19 pandemic, several countries, including Thailand, provided two shots of CoronaVac to healthcare workers. Whereas ChAdOx1 nCoV-19 is the promising vaccine as the booster dose, the data on immunogenicity when administered after CoronaVac have been limited. The pur...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2022-01-01
|
| סדרה: | Vaccines |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2076-393X/10/2/217 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
